OHSU

IRB #

IRB00009594

Title

Cardiovascular Inflammation Reduction Trial (CIRT)

Principal Investigator

Stephen Heitner

Study Purpose

The purpose of this study is to determine whether the study drug (methotrexate, along with folic acid) is effective in reducing heart attacks, strokes or death in people with type 2 diabetes or metabolic syndrome (a group of symptoms which increases the risk of heart disease and diabetes) who have already had at least 1 heart attack.

Medical Condition(s)

Diabetes and metabolic syndrome and the cardiovascular events that can occur in people with these conditions.

Eligibility Criteria

-Men and women age 18+
-Documented heart attack within the past 5 years
-History of type 2 diabetes or metabolic syndrome
Women who are able to become pregnant may not participate in this study.

Age Range

18 - 99

Healthy Volunteers Needed

No

Duration of Participation

About 6 years

Minors Included

No

Contact

Aynun Naher
Study Coordinator
(503) 494-3313

Sponsor

Brigham & Women's Hospital

Recruitment End

04/01/2015

Compensation Provided

Yes

Compensation

Subjects will receive $25 per visit to the clinic beginning with the randomization visit (Visit 4)


Go Back